You are here:

BAY57-1293 active on herpes.


Full Screen
 Detection of HSV-1 variants highly resistant to the helicase-primase inhibitor BAY 57-1293 at high frequency in 2 of 10 recent clinical isolates of HSV-1

ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2

Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease


( 0 Votes On This Page )